A groundbreaking gene therapy showing promise in preventing premature births and treating placental growth insufficiency holds the potential to significantly improve pregnancies worldwide. This revolutionary therapy is being developed by a dedicated team led by Dr. Helen N. Jones from the
Scientists have long sought to understand the various factors that contribute to the prevalence of cancer, and recent research has shed light on a surprising potential culprit: Escherichia coli (E. coli). A study conducted by researchers from the Wellcome Sanger Institute and the University of
Clinical research has long been a cornerstone of advancing medical science, characterized by a significant historical trajectory. Over decades, its momentum has increased with the advent of new knowledge and technologies, enabling the development of improved therapeutics. From the discoveries in
Aging is a complex biological process that affects various cellular functions, including the behavior of stem cells. Recent research has shed light on how aging impacts iron homeostasis in lung stem cells, leading to a reduction in their tumorigenic potential. This article delves into the intricate
The impact of glyphosate exposure on brain health has been a growing concern, and a new study has brought this issue to the forefront. The research highlights the potential link between the widely used herbicide and lasting brain inflammation, which could lead to neurodegenerative diseases such as
In a strategic move to tackle severe blood cancers, Alanis Therapeutics (ATI) has teamed up with KBI Biopharma to enhance the development and manufacturing of ATI's preclinical antibody candidate, ATI-D1. This partnership aims to accelerate the treatment of myelodysplastic syndromes (MDS) and acute
